August 01, 2012 / 15:30 IST
Drugmaker Sanofi India, a unit of France's Sanofi , plans to launch pain relief cream Combiflam across India next January after 18-month-long pilot sales in two South Indian states, a senior executive said on Tuesday.
"The response (for Combiflam cream) has been positive and we are looking at the extension nationally next year," Anindya Chowdhury, senior director, consumer healthcare, Sanofi India, told Reuters.
The pain relief creams and gels market in India is valued at about Rs 500 crore and is dominated by brands such as Moov, owned by Reckitt Benckiser
and Volini, of India's Ranbaxy Laboratories .
Sanofi India also sells about 1.8 billion pain killer tablets, Combiflam, in the country every year, he said. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
